Skip to main content

Table 2 Relative risk of micro-nutrient deficiency

From: Incidence and risk factors of micronutrient deficiency in patients with IBD and intestinal Behçet’s disease: folate, vitamin B12, 25-OH-vitamin D, and ferritin

Variable Uni-variate analysis Multi-variate analysis
OR (95% CI) P-value Adjusted OR (95% CI) P-value
Male sex 0.842 (0.478–1.485) 0.553 0.718 (0.375–1.376) 0.319
Age 0.975 (0.958–0.993) 0.006 0.973 (0.949–0.998) 0.037
The path of laboratory test     
 Outpatients clinic 1.0 (Ref.)   1.0 (Ref.)  
 Hospitalization patients 2.204 (0.735–6.608) 0.158 2.459 (0.715–8.461) 0.154
Type of disease     
 UC 1.0 (Ref.)   1.0 (Ref.)  
 CD 3.810 (1.721–8.430) 0.001 2.492 (1.012–6.136) 0.047
 Intestinal BD 2.778 (0.734–10.513) 0.132 1.356 (0.284–6.479) 0.703
Medications     
 5-ASA 0.381 (0.214–0.679) 0.001 0.548 (0.281–1.068) 0.077
 Steroids 0.502 (0.132–1.914) 0.313   
 Azathioprine 1.784 (0.983–3.238) 0.057   
 Anti-TNF 1.584 (0.900–2.788) 0.111   
 Methotrexate 0.746 (0.340–1.637) 0.465   
 Othersa 0.295 (0.063–1.383) 0.121   
Operation 2.041 (1.120–3.717) 0.020 2.714 (1.260–5.844) 0.011
Underlying disease     
 Hypertension 0.515 (0.053–5.037) 0.568   
 Osteoporosis 0.776 (0.371–1.624) 0.501 1.500 (0.699–3.217) 0.298
 Othersb 1.131 (0.579–2.206) 0.719 2.459 (0.715–8.461) 0.154
  1. OR, odds ratio; CI, confidence interval; UC, Ulcerative colitis; CD, Crohn’s disease; BD, Behçet’s disease; 5-ASA, 5-aminosalicylic acid; anti-TNF, anti-tumor necrosis factor
  2. aMongersen, vedolizumab
  3. bMDS, SLE, AR, BOOP, OA, Osteoporosis, CAOD, cancer
\